1. Introduction
Vietnams healthcare system has expanded rapidly in the last two decades, yet the integration of clinical pharmacy services remains limited in most public hospitals. Clinical pharmacydefined as the direct involvement of pharmacists in patient care, medication therapy management, and interdisciplinary collaborationhas demonstrated benefits worldwide, including reduced adverse drug events, shorter hospital stays, and lower healthcare costs. This page outlines the rationale, key activities, implementation steps, challenges, and policy recommendations for establishing robust clinical pharmacy programmes in Vietnamese hospitals.
2. Why Clinical Pharmacy Is Needed in Vietnam
Several factors underline the urgency of scaling clinical pharmacy:
- High medication use. In 2023, over 70% of inpatients received at least one medication, and polypharmacy (5 drugs) affected 35% of older adults.
- Adverse drug reactions (ADRs). National pharmacovigilance reports estimate ~12% of hospitalized patients experience a serious ADR, many of which are preventable.
- Antimicrobial resistance. Inappropriate antibiotic prescribing remains a major driver of resistance, especially in tertiary care centres.
- Workforce gaps. Pharmacists are often confined to dispensing roles, with limited training in clinical decisionmaking.
Addressing these issues through clinical pharmacy can improve patient safety, optimise therapy, and support the Ministry of Healths goals for universal health coverage.
3. Core Clinical Pharmacy Activities
The following activities constitute the backbone of a functional clinical pharmacy service:
| Activity | Key Functions |
|---|---|
| Medication Reconciliation | Collecting a complete medication history on admission, verifying accuracy, and updating the record at transfer or discharge. |
| Medication Review & Therapy Optimization | Assessing appropriateness, dosing, interactions, and therapeutic duplication; recommending changes to prescribers. |
| Antimicrobial Stewardship | Guiding empirical therapy, deescalation, duration, and monitoring of drug levels; educating prescribers. |
| Clinical Rounds | Participating in multidisciplinary rounds, providing realtime drug information, and documenting interventions. |
| Patient Education & Counseling | Explaining drug regimen, sideeffects, adherence strategies, and providing written materials. |
| Pharmacovigilance & ADR Reporting | Identifying, documenting, and analysing ADRs; communicating signals to hospital committees. |
| Therapeutic Drug Monitoring (TDM) | Ordering and interpreting plasma concentrations for narrowindex drugs (e.g., vancomycin, aminoglycosides). |
| Continuing Professional Development | Organising journal clubs, workshops, and competency assessments for pharmacy staff. |
4. StepbyStep Implementation Roadmap
- Stakeholder Engagement
- Form an implementation committee including hospital directors, physicians, senior pharmacists, and Ministry of Health representatives.
- Conduct needsassessment surveys to identify highrisk units (e.g., ICU, oncology).
- Define Service Scope
- Start with pilot units (e.g., internal medicine) and gradually expand.
- Set measurable objectives: number of medication reconciliations, ADRs prevented, antibiotic days saved.
- Recruit & Train Clinical Pharmacists
- Allocate at least one pharmacist per 30 beds; prioritize candidates with residency or postgraduate training.
- Partner with universities (e.g., Hanoi Medical University) for onthejob training modules.
- Develop Standard Operating Procedures (SOPs)
- Document workflows for each activity, including documentation templates in the electronic health record (EHR).
- Integrate national treatment guidelines and WHO Essential Medicines List.
- Integrate Into Hospital Information Systems
- Configure the EHR to allow pharmacists to write orders, flag interactions, and capture intervention outcomes.
- Enable automatic alerts for highrisk drugs and duplicate therapy.
- Launch Pilot & Collect Data
- Track key performance indicators (KPIs) weekly.
- Hold monthly multidisciplinary review meetings to discuss barriers and successes.
- Scale Up & Sustain
- Use pilot results to justify budget allocation for additional staff.
- Establish a hospitalwide clinical pharmacy department with dedicated leadership.
5. Expected Benefits
Evidence from neighboring countries (Thailand, Malaysia) indicates that each fulltime clinical pharmacist can prevent up to 15% of serious medication errors. Anticipated outcomes for Vietnamese hospitals include:
- Patient safety: 2030% reduction in preventable ADRs.
- Clinical outcomes: Shorter average length of stay by 0.81.2days in highrisk units.
- Economic impact: Cost savings of USD1,2002,500 per bed per year from avoided complications.
- Antimicrobial use: 15% decrease in broadspectrum antibiotic consumption.
6. Challenges and Mitigation Strategies
Implementing clinical pharmacy in Vietnam faces several obstacles:
- Limited trained workforce Mitigation: Offer scholarships for clinical pharmacy residencies and fasttrack certification programs.
- Resistance from physicians Mitigation: Demonstrate value through pilot data, involve physicians in SOP development, and promote joint case discussions.
- Inadequate IT infrastructure Mitigation: Seek government or donor funding for EHR upgrades; use lowcost decisionsupport tools where full integration is not possible.
- Financial constraints Mitigation: Present costbenefit analyses to hospital boards; explore billing models that reimburse pharmacistled services.
7. Policy Recommendations for National ScaleUp
To institutionalise clinical pharmacy across Vietnam, the Ministry of Health and professional bodies should consider:
- Mandating a minimum clinical pharmacisttobed ratio in all tertiary and secondary hospitals.
- Incorporating clinical pharmacy competencies into the national pharmacy licensure examination.
- Providing dedicated reimbursement codes for medication therapy management and antimicrobial stewardship interventions.
- Creating a national registry of clinical pharmacy services to monitor performance and share best practices.
- Supporting research grants focused on pharmacoeconomics and outcomes of clinical pharmacy in the Vietnamese context.
8. Conclusion
Clinical pharmacy has the potential to transform medication use, enhance patient safety, and reduce healthcare costs in Vietnams hospitals. By adopting a phased implementation plan, investing in workforce development, and aligning policies with international best practices, Vietnam can build a sustainable clinical pharmacy ecosystem that meets the needs of its growing patient population.
For further reading and resources, visit the World Health Organization and the Vietnam Ministry of Health websites.
